Global Bio-pharma Market Research Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Bio-pharma Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Bio-pharma Market Overview:
Global Bio-pharma Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Bio-pharma involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Bio-pharma Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Bio-pharma market in 2020.
Global Bio-pharma Market Segmentation
By Type, Bio-pharma market has been segmented into:
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others
By Application, Bio-pharma market has been segmented into:
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Bio-pharma market are:
Pfizer
F. Hoffmann-La Roche AG
Johnson & Johnson Services
Sanofi
Amgen
AbbVie
Merck & Co.
Biogen Idec
Bayer AG
Eli Lilly and Company
Novartis AG GlaxoSmithKline Plc
Bristol-Myers Squibb Company
AstraZeneca PLC
Abbott Laboratories
1. Market Overview of Bio-pharma
1.1 Bio-pharma Market Overview
1.1.1 Bio-pharma Product Scope
1.1.2 Market Status and Outlook
1.2 Bio-pharma Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Bio-pharma Historic Market Size by Regions (2015-2020)
1.4 Bio-pharma Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Bio-pharma Sales Market by Type (2015-2026)
2.1 Global Bio-pharma Historic Market Size by Type (2015-2020)
2.2 Global Bio-pharma Forecasted Market Size by Type (2021-2026)
2.3 Monoclonal Antibodies
2.4 Recombinant Proteins
2.5 Granulocyte-Colony Stimulating Factor (G-CSF)
2.6 Interferons
2.7 Recombinant Human Insulin
2.8 Erythropoietin
2.9 Vaccines
2.10 Growth Hormones
2.11 Purified Proteins
2.12 Others
3. Covid-19 Impact Bio-pharma Sales Market by Application (2015-2026)
3.1 Global Bio-pharma Historic Market Size by Application (2015-2020)
3.2 Global Bio-pharma Forecasted Market Size by Application (2021-2026)
3.3 Metabolic Disorders
3.4 Oncology
3.5 Neurological Disorders
3.6 Cardiovascular Diseases
3.7 Inflammatory and Infectious Diseases
3.8 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Bio-pharma Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Bio-pharma Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Bio-pharma Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Bio-pharma Business
5.1 Pfizer
5.1.1 Pfizer Company Profile
5.1.2 Pfizer Bio-pharma Product Specification
5.1.3 Pfizer Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 F. Hoffmann-La Roche AG
5.2.1 F. Hoffmann-La Roche AG Company Profile
5.2.2 F. Hoffmann-La Roche AG Bio-pharma Product Specification
5.2.3 F. Hoffmann-La Roche AG Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Johnson & Johnson Services
5.3.1 Johnson & Johnson Services Company Profile
5.3.2 Johnson & Johnson Services Bio-pharma Product Specification
5.3.3 Johnson & Johnson Services Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Sanofi
5.4.1 Sanofi Company Profile
5.4.2 Sanofi Bio-pharma Product Specification
5.4.3 Sanofi Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Amgen
5.5.1 Amgen Company Profile
5.5.2 Amgen Bio-pharma Product Specification
5.5.3 Amgen Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 AbbVie
5.6.1 AbbVie Company Profile
5.6.2 AbbVie Bio-pharma Product Specification
5.6.3 AbbVie Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Merck & Co.
5.7.1 Merck & Co. Company Profile
5.7.2 Merck & Co. Bio-pharma Product Specification
5.7.3 Merck & Co. Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Biogen Idec
5.8.1 Biogen Idec Company Profile
5.8.2 Biogen Idec Bio-pharma Product Specification
5.8.3 Biogen Idec Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Bayer AG
5.9.1 Bayer AG Company Profile
5.9.2 Bayer AG Bio-pharma Product Specification
5.9.3 Bayer AG Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Eli Lilly and Company
5.10.1 Eli Lilly and Company Company Profile
5.10.2 Eli Lilly and Company Bio-pharma Product Specification
5.10.3 Eli Lilly and Company Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Novartis AG GlaxoSmithKline Plc
5.11.1 Novartis AG GlaxoSmithKline Plc Company Profile
5.11.2 Novartis AG GlaxoSmithKline Plc Bio-pharma Product Specification
5.11.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Bristol-Myers Squibb Company
5.12.1 Bristol-Myers Squibb Company Company Profile
5.12.2 Bristol-Myers Squibb Company Bio-pharma Product Specification
5.12.3 Bristol-Myers Squibb Company Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 AstraZeneca PLC
5.13.1 AstraZeneca PLC Company Profile
5.13.2 AstraZeneca PLC Bio-pharma Product Specification
5.13.3 AstraZeneca PLC Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 Abbott Laboratories
5.14.1 Abbott Laboratories Company Profile
5.14.2 Abbott Laboratories Bio-pharma Product Specification
5.14.3 Abbott Laboratories Bio-pharma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Bio-pharma Market Size (2015-2026)
6.2 North America Bio-pharma Key Players in North America (2015-2020)
6.3 North America Bio-pharma Market Size by Type (2015-2020)
6.4 North America Bio-pharma Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Bio-pharma Market Size (2015-2026)
7.2 East Asia Bio-pharma Key Players in North America (2015-2020)
7.3 East Asia Bio-pharma Market Size by Type (2015-2020)
7.4 East Asia Bio-pharma Market Size by Application (2015-2020)
8. Europe
8.1 Europe Bio-pharma Market Size (2015-2026)
8.2 Europe Bio-pharma Key Players in North America (2015-2020)
8.3 Europe Bio-pharma Market Size by Type (2015-2020)
8.4 Europe Bio-pharma Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Bio-pharma Market Size (2015-2026)
9.2 South Asia Bio-pharma Key Players in North America (2015-2020)
9.3 South Asia Bio-pharma Market Size by Type (2015-2020)
9.4 South Asia Bio-pharma Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Bio-pharma Market Size (2015-2026)
10.2 Southeast Asia Bio-pharma Key Players in North America (2015-2020)
10.3 Southeast Asia Bio-pharma Market Size by Type (2015-2020)
10.4 Southeast Asia Bio-pharma Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Bio-pharma Market Size (2015-2026)
11.2 Middle East Bio-pharma Key Players in North America (2015-2020)
11.3 Middle East Bio-pharma Market Size by Type (2015-2020)
11.4 Middle East Bio-pharma Market Size by Application (2015-2020)
12. Africa
12.1 Africa Bio-pharma Market Size (2015-2026)
12.2 Africa Bio-pharma Key Players in North America (2015-2020)
12.3 Africa Bio-pharma Market Size by Type (2015-2020)
12.4 Africa Bio-pharma Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Bio-pharma Market Size (2015-2026)
13.2 Oceania Bio-pharma Key Players in North America (2015-2020)
13.3 Oceania Bio-pharma Market Size by Type (2015-2020)
13.4 Oceania Bio-pharma Market Size by Application (2015-2020)
14. South America
14.1 South America Bio-pharma Market Size (2015-2026)
14.2 South America Bio-pharma Key Players in North America (2015-2020)
14.3 South America Bio-pharma Market Size by Type (2015-2020)
14.4 South America Bio-pharma Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Bio-pharma Market Size (2015-2026)
15.2 Rest of the World Bio-pharma Key Players in North America (2015-2020)
15.3 Rest of the World Bio-pharma Market Size by Type (2015-2020)
15.4 Rest of the World Bio-pharma Market Size by Application (2015-2020)
16 Bio-pharma Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Bio pharma Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|